NF-κB is constitutively activated in primary pancreatic adenocarcinoma and pancreatic cancer cell lines [8], and downregulated NF-κB forms the biological rationale for effective management of patients with pancreatic carcinoma by using a nontoxic phytochemical [11]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.